The objective of this contract is to produce, scale-up, characterize and formulate reagent grade (GLP) and /or clinical grade (cGMP) HIV-1vector-based vaccine products for animal and/or human trials. For clinical grade materials the manufacturer must perform all required vaccine lot characterization tests. The contractor must also work together with other contractors performing safety and immunogenicity testing of the vaccine product or producing FDA-required documentation in support of an IND.

Project Start
1999-07-07
Project End
2006-07-06
Budget Start
1999-07-07
Budget End
2000-07-06
Support Year
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Therion Biologics Corporation
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142